Neurology® Podcast

The March 2026 recall showcases four previously posted episodes focused on clinical issues relevant to hospital-based neurologists. The episode opens with Dr. Jennifer E. Fugate discussing PRES, focusing on clinical presentation, diagnostic criteria, neuroimaging findings, and management strategies. The episode continues with Dr. Ava Easton discussing the World Health Organization's technical brief on encephalitis. In the third episode, Dr. Matthew Ryan Woodward discusses the complexities of status epilepticus, from definition through refractory and super-refractory stages. The episode concludes with Dr. Adrian Budhram discussing common challenges neurologists face when interpreting CSF results.

Podcast links:

Evolving Insights into the Diagnosis, Management, and Outcomes of PRES

WHO Launches Technical Brief for Encephalitis

Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication

CSF Correction Factors for Traumatic Lumbar Puncture in Adults

Article links:

Posterior Reversible Encephalopathy Syndrome: Evolving Insights in Diagnosis, Management, and Outcomes

WHO Launches Technical Brief for Encephalitis

Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication

Clinical Utility of CSF Correction Factors for Traumatic Lumbar Puncture in Adults

Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Shyam Prabhakaran about the 2026 AHA/ASA guidelines for the early management of acute ischemic stroke, highlighting key recommendations, the role of advanced imaging, and the importance of thrombolysis and thrombectomy.

Read the related article in the journal Stroke.

Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Marjo S. van der Knaap and Romy J. van Voorst about expert consensus recommendations for the diagnosis and management of vanishing white matter and the importance of standardizing care worldwide.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Alex Menze talks with Dr. Divyanshu Dubey about the clinical insights into autoimmune nodopathies, particularly focusing on CASPR1 and CASPR1/CNTN1-complex-IgG.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Halley Alexander talks with Dr. Alissa M. D'Gama about genetic testing for infantile epilepsies.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Greg Cooper talks with Dr. David G. Coughlin about the role of αSyn-SAAs in diagnosing dementia with Lewy bodies and their relationship with Alzheimer disease biomarkers.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Tesha Monteith talks with Dr. Andrew D. Hershey about the advancements in the treatment of pediatric migraines.

Read the related article in The New England Journal of Medicine.

Disclosures can be found at Neurology.org.

In this special episode, Dr. Roy Strowd talks with Drs. Jeff Ratliff, Tesha Monteith, and Justin Abbatemarco about non-traditional educational formats and how they're reshaping neurology training.

Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Dipika Aggarwal as she shares her profound journey as both a physician and a patient. After battling stage four colon cancer, she faced a stroke that changed her life.

Disclosures can be found at Neurology.org.

The February 2026 recall features four previously posted episodes on multiple sclerosis. The episode begins with a conversation with Dr. Wallace J. Brownle discussing whether dissemination in time is essential to diagnois relapsing MS. The discussion continues with Dr. Daniel Ontaneda regarding the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis. The episode then transitions into a conversation with Dr. Jiwon Oh about BTK inhibitors and recent data on tolebrutinib in multiple sclerosis. The episode concludes with Dr. Sandra Vukusic addressing the differences in disease-modifying therapies for female versus male patients with multiple sclerosis.

Podcast link:

Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS

2024 McDonald Criteria

BTK Inhibitors in Multiple Sclerosis Treatment

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis

Podcast article:

Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing Multiple Sclerosis

Diagnosis of Multiple Sclerosis: 2024 Revisions of the McDonald Criteria

Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis

Disclosures can be found at Neurology.org.